tiprankstipranks
Aileron Therapeutics Inc (ALRN)
NASDAQ:ALRN

Aileron Therapeutics (ALRN) Financial Statements

1,182 Followers

Aileron Therapeutics Financial Overview

Aileron Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.191; its P/E ratio is -0.86; Aileron Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.11M$ -7.34M$ -1.83M$ -1.79M$ -4.78M
EBITDA$ -7.05M$ -7.10M$ -1.82M$ -1.83M$ -4.84M
Net Income Common Stockholders$ -7.11M$ -7.34M$ -1.83M$ -1.79M$ -4.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.04M$ 17.31M$ 12.07M$ 13.69M$ 16.75M
Total Assets$ 99.19M$ 106.01M$ 12.82M$ 13.99M$ 17.16M
Total Debt$ 0.00$ 48.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -12.04M$ -17.27M$ -12.07M$ -13.69M$ -16.75M
Total Liabilities$ 7.86M$ 7.71M$ 1.62M$ 1.20M$ 2.88M
Stockholders Equity$ 44.75M$ 6.89M$ 11.20M$ 12.79M$ 14.27M
Cash Flow-
Free Cash Flow$ -5.27M$ -10.39M$ -1.60M$ -3.12M$ -4.66M
Operating Cash Flow$ -5.27M$ -10.39M$ -1.64M$ -3.12M$ -4.66M
Investing Cash Flow-$ -96.00K$ 542.00K$ 8.50M$ 7.25M
Financing Cash Flow-$ 15.79M---
Currency in USD

Aileron Therapeutics Earnings and Revenue History

Aileron Therapeutics Debt to Assets

Aileron Therapeutics Cash Flow

Aileron Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis